Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH ASTRAZENECA PHARMA PROCTER & GAMBLE HEALTH/
ASTRAZENECA PHARMA
 
P/E (TTM) x 34.5 95.5 36.1% View Chart
P/BV x 10.5 22.7 46.3% View Chart
Dividend Yield % 2.0 0.3 671.2%  

Financials

 PROCTER & GAMBLE HEALTH   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
ASTRAZENECA PHARMA
Mar-23
PROCTER & GAMBLE HEALTH/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs5,3663,620 148.2%   
Low Rs3,8832,438 159.3%   
Sales per share (Unadj.) Rs740.7401.2 184.6%  
Earnings per share (Unadj.) Rs138.239.7 348.1%  
Cash flow per share (Unadj.) Rs155.246.2 335.7%  
Dividends per share (Unadj.) Rs95.0016.00 593.8%  
Avg Dividend yield %2.10.5 388.9%  
Book value per share (Unadj.) Rs447.6234.4 190.9%  
Shares outstanding (eoy) m16.6025.00 66.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.27.5 82.7%   
Avg P/E ratio x33.576.3 43.9%  
P/CF ratio (eoy) x29.865.5 45.5%  
Price / Book Value ratio x10.312.9 80.0%  
Dividend payout %68.740.3 170.6%   
Avg Mkt Cap Rs m76,76175,718 101.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,0622,591 79.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,29610,030 122.6%  
Other income Rs m184261 70.5%   
Total revenues Rs m12,48010,291 121.3%   
Gross profit Rs m3,2471,249 260.0%  
Depreciation Rs m281163 172.8%   
Interest Rs m86 122.2%   
Profit before tax Rs m3,1421,341 234.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m847348 243.4%   
Profit after tax Rs m2,295993 231.1%  
Gross profit margin %26.412.5 212.1%  
Effective tax rate %27.026.0 103.9%   
Net profit margin %18.79.9 188.5%  
BALANCE SHEET DATA
Current assets Rs m11,7139,359 125.1%   
Current liabilities Rs m6,7914,844 140.2%   
Net working cap to sales %40.045.0 88.9%  
Current ratio x1.71.9 89.3%  
Inventory Days Days26349 531.1%  
Debtors Days Days34339 877.8%  
Net fixed assets Rs m10,6172,061 515.0%   
Share capital Rs m16650 332.0%   
"Free" reserves Rs m7,2655,811 125.0%   
Net worth Rs m7,4315,861 126.8%   
Long term debt Rs m00-   
Total assets Rs m22,33011,421 195.5%  
Interest coverage x409.1213.9 191.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.9 62.7%   
Return on assets %10.38.7 117.9%  
Return on equity %30.916.9 182.3%  
Return on capital %42.423.0 184.4%  
Exports to sales %00-   
Imports to sales %13.137.4 34.9%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m1,6053,747 42.8%   
Fx inflow Rs m1,465612 239.4%   
Fx outflow Rs m1,6053,747 42.8%   
Net fx Rs m-140-3,135 4.5%   
CASH FLOW
From Operations Rs m2,360583 404.9%  
From Investments Rs m-215181 -118.7%  
From Financial Activity Rs m-985-245 402.2%  
Net Cashflow Rs m1,160519 223.5%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 20.3 5.4 373.8%  
FIIs % 7.6 2.7 285.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 25.0 192.7%  
Shareholders   56,730 29,032 195.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs ASTRAZENECA PHARMA Share Price Performance

Period Procter & Gamble Health ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day -0.55% 0.01% 1.18%
1-Month -7.47% -3.61% -0.75%
1-Year -3.02% 59.20% 61.82%
3-Year CAGR -9.12% 20.50% 18.16%
5-Year CAGR 5.75% 22.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.